Reuters - Health Report

Click to View in Browser

Thursday, June 22, 2017

Senate healthcare bill expected to cut back Medicaid expansion

WASHINGTON (Reuters) - A healthcare bill being unveiled by U.S. Senate Republicans on Thursday is expected to roll back the Obamacare expansion of the Medicaid healthcare program for the poor and reshape subsidies to low-income people buying private insurance.

Most U.S. teens have sex by 18, but pregnancies down: CDC study

(Reuters) - More than half of American teens have had sex by age 18, but teenage pregnancy and birth rates extended their 2-1/2-decade decline because of increased contraceptive use, according to a U.S. government study released on Thursday.

Surprise win for anti-inflammatory heart drug boosts Novartis

ZURICH/LONDON (Reuters) - A Novartis drug designed to reduce inflammation has shown surprising efficacy in cutting cardiovascular risk for people who had survived a heart attack, potentially changing ideas about treatment and boosting the company's shares.

Draft Senate healthcare bill would link subsidies to income: Washington Post

WASHINGTON (Reuters) - Senate Republicans would repeal most of the taxes that pay for Obamacare, roll back expanded Medicaid coverage under the healthcare law approved in 2010, reshape its subsidies, give states wider latitude to opt out of its regulations and eliminate federal funding for Planned Parenthood, under a draft bill reported by the Washington Post on Wednesday.

Most Americans say Republican healthcare plan will be harmful: Reuters/Ipsos poll

NEW YORK (Reuters) - When U.S. Senate Republicans unveil their plan to overhaul America's healthcare system, they will face a skeptical public that already does not buy the justification for an earlier version that passed the House of Representatives, according to a Reuters/Ipsos poll released on Wednesday.

Cigna stays in Obamacare for now; Anthem reduces participation

NEW YORK (Reuters) - U.S. healthcare insurer Cigna Corp said on Wednesday it will continue to offer individual coverage under Obamacare for now while rival Anthem Inc announced it was shrinking its participation, amid uncertainty over the fate of the government-subsidized program.

Ohio county claims top spot in America’s opioid death spiral

DAYTON, Ohio (Reuters) - Scott Weidle is struggling with the death of his son Daniel, who died from a heroin overdose 18 months ago, one day after Christmas.

Anti-abortion activists lose bid to dismiss California privacy case

SAN FRANCISCO (Reuters) - Two anti-abortion activists charged with felony eavesdropping for secretly filming abortion providers in California lost their bid for dismissal of the case on Wednesday, but the judge ordered prosecutors to amend a criminal complaint he deemed too vague.

GSK wins $235 million from Teva in Coreg patent trial

(Reuters) - A U.S. jury has ordered Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than $235 million for infringing a patent covering its blood pressure drug Coreg, court documents showed.

Drugmaker Mylan gets boost from unlikely source: coal

NEW YORK (Reuters) - Mylan N.V. is best known for producing EpiPen emergency allergy treatments and generic drugs.